Analyst consensus rating
Century Therapeutics, Inc. Analyst Consensus Rating
IPSC analyst consensus rating, coverage count and price target evidence.
Direct answer
Century Therapeutics, Inc.'s consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.75.
Forecast evidence checked August 13, 2026.
Get free Century Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.98
- Average price target
- $4.75
- High price target
- $8.00
- Low price target
- $2.00
- Target upside
- +139.9%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026